Sign in
WithdrawnNo phase

The Usefulness of Coronary CT Scan After Everolimus-eluting Bioabsorbable Scaffold Implantation for Coronary Artery Disease

Key facts

Who runs it
Jung-min Ahn
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Started
Dec 2021
Ended
Dec 2023
Type of study
Observational
Treatments tested
  • Computed tomographic scan
Record updated
23 July 2021
Why it stopped
This study will be revived with retrospective design.

Who can take part

Age
19 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patients treated withBioresobable Vascular Scaffold for coronary disease

Who cannot take part

  • History of allergy to contrast
  • Severe arrhythmia
  • Serum Creatinine > 2.0 mg/dl
  • Pregnancy or breast feeding

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to evaluate usefulness of coronary computed tomographic scan for prediction of clinical events after everolimus-eluting bioabsorbable scaffold implantation for coronary artery disease.

The group in the trial

  • bioabsorbable scaffold

    Patients with BVS(bioabsorbable scaffold) for coronary stenosis

    Treatment: Computed tomographic scan

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Usefulness of Coronary CT Scan After Everolimus-eluting Bioabsorbable Scaffold Implantation for Coronary Artery Disease; A Single Center, Prospective Observational Study
Record updated
23 July 2021